Sleep News

Parkinson's disease is an explicit qualifying condition for Minnesota's medical cannabis program. This 2026 guide covers the clinical evidence for tremor, REM Sleep Behavior Disorder, and pain, along with critical drug interactions with levodopa, MAO-B inhibitors, and dopamine agonists — and why CBD-dominant products are the safest starting point for most Parkinson's patients.

Fibromyalgia affects millions of Americans, and a growing body of research suggests CBD-dominant cannabis can help manage widespread pain, sleep disruption, and fibro fog. Here is what Minnesota fibromyalgia patients need to know about qualifying for the medical program, choosing products, and navigating drug interactions with Lyrica, Cymbalta, and tramadol.

Sleep problems are the most common reason Minnesotans visit a dispensary. Here is what the clinical evidence actually shows about THC, CBD, and CBN for insomnia, plus drug interactions and which qualifying conditions apply in Minnesota.

Adults 65 and older are the fastest-growing cannabis consumer segment. This guide covers how aging changes your cannabis experience, the strongest evidence for chronic pain, arthritis, sleep, and anxiety, drug interactions seniors must know (warfarin, blood thinners, sedatives), best product types, dosing guidance, Minnesota qualifying conditions for a medical card, and how to navigate a dispensary for the first time.

CBD, THC, and athletic recovery: what the science says, WADA and NCAA rules, what to buy at Minnesota dispensaries for soreness and sleep, and what every Minnesota athlete needs to know about drug testing.